Treatment of Pancreatic Neuroendocrine Tumors: How It Works, Results and What to Expect

Treatment of pancreatic neuroendocrine tumors is individualized according to the tumor’s size, grade, hormone activity, location, and whether it has spread. Many people can live with a pancreatic neuroendocrine tumor for years, particularly when it is slow-growing and managed by an experienced multidisciplinary team.

Overview: How Treatment of Pancreatic Neuroendocrine Tumors Works

Treatment of pancreatic neuroendocrine tumors aims to remove or control the tumor, manage hormone-related symptoms when present, and preserve quality of life. The best plan depends on whether the tumor is localized to the pancreas, has spread to areas such as the liver, produces excess hormones, and appears slow- or fast-growing under the microscope.

Pancreatic neuroendocrine tumors, also called PanNETs or pNETs, develop from neuroendocrine cells in the pancreas. They differ from the more common pancreatic adenocarcinoma and can behave very differently. Some are nonfunctioning, meaning they do not cause an identifiable hormone syndrome, while functioning tumors release hormones that may cause specific symptoms.

A specialist team commonly includes medical oncologists, endocrinologists, gastroenterologists, pancreatic surgeons, radiologists, nuclear medicine physicians, pathologists, dietitians, and supportive-care professionals. The team reviews pathology, imaging, symptoms, general health, and personal priorities before recommending a treatment pathway.

How Serious Is a Pancreatic Neuroendocrine Tumor?

A pancreatic neuroendocrine tumor can range from a small, slow-growing tumor that is monitored over time to an aggressive cancer requiring prompt systemic treatment. Its seriousness cannot be judged by symptoms alone. Doctors assess the tumor’s grade, Ki-67 proliferation index, size, invasion into nearby structures, lymph-node involvement, and spread to distant organs.

Lower-grade tumors often grow more slowly and may be managed over a long period. Higher-grade neuroendocrine neoplasms can grow more rapidly and usually need more urgent, intensive treatment. A pathology review is particularly important because treatment choices differ between well-differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.

Even when a tumor has spread, treatment may help control growth and symptoms for a meaningful period. People should ask their care team about the tumor grade and stage, whether it has receptors that may guide therapy, and the goals of treatment in their individual situation.

How Fast Does a Neuroendocrine Tumor Grow?

Neuroendocrine tumors do not all grow at the same rate. Many well-differentiated pancreatic neuroendocrine tumors grow gradually, sometimes over years, while others have more active biology. The growth rate is estimated through repeated scans and by examining tumor tissue for features such as the Ki-67 index and mitotic count.

For carefully selected people with a small, nonfunctioning, low-grade tumor and no concerning features, active surveillance may be an appropriate first step. This means scheduled imaging and clinical follow-up rather than immediate treatment. Surveillance is an active medical strategy, not a decision to ignore the tumor.

More frequent assessment may be advised if imaging shows growth, if symptoms develop, if the tumor is larger or higher grade, or if there is evidence of spread. A doctor can explain what rate of change would alter the treatment plan.

Candidacy and the Main Treatment Options

There is no single procedure that suits every pancreatic neuroendocrine tumor. Surgery may be recommended for localized tumors that can be removed safely, for functioning tumors causing significant hormone-related symptoms, or in selected cases where removing tumor deposits may improve disease control. The operation may involve enucleation of a small tumor, distal pancreatectomy, or pancreaticoduodenectomy, depending on the location.

For small, low-risk tumors, observation with regular imaging can avoid or postpone the risks of pancreatic surgery. If disease is advanced or cannot be fully removed, treatment may include somatostatin analogues for selected receptor-positive tumors, targeted medicines, chemotherapy for particular tumor types, or peptide receptor radionuclide therapy (PRRT) when appropriate.

When tumor spread is mainly in the liver, selected patients may be considered for liver-directed approaches, such as embolization or ablation, alongside systemic treatment. The choice is guided by tumor extent, liver function, receptor imaging, symptoms, previous therapies, and overall health.

• Localized and removable tumor: surgery may offer the best opportunity for complete removal.
• Small, low-risk tumor: structured monitoring may be considered.
• Hormone-producing tumor: symptom control and tumor-directed treatment are both important.
• Advanced disease: treatment focuses on controlling tumor growth, symptoms, and treatment-related effects.

What to Expect: Evaluation, Treatment Steps and Recovery

Before treatment begins, evaluation typically includes contrast-enhanced CT or MRI, blood and urine tests when hormone excess is suspected, and review of a biopsy or surgical pathology sample. Specialized functional imaging, often using a somatostatin receptor tracer, may help show where disease is present and whether receptor-targeted therapy could be suitable.

If surgery is planned, the team explains the type of operation, preparation, expected hospital stay, pain control, nutrition plan, and possible need for enzyme or blood-sugar monitoring afterward. During surgery, the surgeon removes the tumor and, when needed, nearby pancreatic tissue or lymph nodes. The exact approach may be open, laparoscopic, or robotic depending on anatomy and surgical judgment.

Recovery after pancreatic surgery varies by operation and individual health. Early recovery includes monitoring for pain, infection, bleeding, pancreatic fluid leakage, digestive changes, and changes in blood glucose. Some people need temporary dietary adjustments, pancreatic enzyme replacement, or diabetes care; others do not. Follow-up imaging and pathology results guide the next steps.

For non-surgical treatments, visits may involve injections, oral medicines, infusions, or nuclear medicine therapy given in planned cycles. The care team monitors blood counts, kidney and liver function, symptoms, and scan results to assess benefits and identify side effects early.

Benefits, Risks and Supportive Care

The potential benefit of treatment is different for each person. Surgery may remove a localized tumor, while medication-based, radionuclide, and liver-directed treatments may slow progression, shrink some tumors, reduce hormone-related symptoms, or help maintain daily function. In some circumstances, the most appropriate goal is long-term disease control rather than cure.

Possible surgical risks include bleeding, infection, blood clots, delayed stomach emptying, leakage of pancreatic fluid, and changes in digestion or blood sugar. Medicine-based treatments can also cause side effects, which vary by therapy and may include fatigue, nausea, changes in bowel habits, low blood counts, or effects on kidney, liver, or blood glucose function. The treating team discusses individual risks before treatment.

Supportive care should be part of treatment from the beginning. It may include nutritional advice, management of diarrhea or abdominal symptoms, diabetes support, pain relief, emotional support, and help coordinating appointments. Keeping a symptom record can help clinicians distinguish hormone-related symptoms, treatment effects, and unrelated health concerns.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and treatment planning for international patients with pancreatic neuroendocrine tumors.

How Long Can You Live With a Pancreatic Neuroendocrine Tumor?

Life expectancy with a pancreatic neuroendocrine tumor varies greatly, so an individual estimate should come from the treating oncology team. Important factors include whether the tumor is localized or metastatic, its grade and differentiation, how quickly it changes on scans, whether it produces hormones, available treatment options, and the person’s general health.

Many people with well-differentiated pancreatic neuroendocrine tumors live for years, including some with metastatic disease, because these tumors can often be managed with sequential treatments and close follow-up. However, higher-grade tumors may have a more uncertain outlook and can require faster treatment.

Rather than relying on general survival figures, it is helpful to ask about the specific tumor biology, treatment goals, expected monitoring schedule, and signs that would suggest the plan needs to change. Prognosis is best revisited over time as new scan and treatment-response information becomes available.

Can You Live With a Neuroendocrine Tumor? When to Seek Medical Care

Yes. Many people live with a neuroendocrine tumor while receiving monitoring or treatment, and continue work, family life, and everyday activities with appropriate support. The experience varies, especially when tumors produce hormones or when treatment affects digestion, energy, or blood sugar, but symptom management and regular follow-up can make an important difference.

Medical care should be sought promptly for new or worsening persistent abdominal pain, unexplained weight loss, yellowing of the skin or eyes, repeated vomiting, severe diarrhea, flushing with dizziness, episodes of confusion or fainting, or symptoms suggesting very low or very high blood sugar. These symptoms have many possible causes, but they deserve timely assessment.

People already diagnosed with a pancreatic neuroendocrine tumor should contact their care team if symptoms change, treatment side effects become difficult to manage, or they have concerns between scheduled appointments. Regular surveillance remains important even after apparently successful treatment, because follow-up is tailored to the individual risk of recurrence or progression.

Frequently asked questions

What is the first-line treatment of pancreatic neuroendocrine tumors?

First-line treatment depends on the tumor’s size, grade, location, symptoms, and extent of spread. Surgery is often considered for a localized tumor that can be safely removed, while surveillance or medicine-based treatment may be more suitable in other situations. A multidisciplinary review helps determine the most appropriate initial plan.

Is surgery always needed for a pancreatic neuroendocrine tumor?

No. Some small, low-grade, nonfunctioning tumors can be monitored with scheduled imaging rather than treated immediately. Surgery may be recommended when the tumor is larger, growing, producing hormones, causing symptoms, or considered removable with an acceptable risk profile.

Can pancreatic neuroendocrine tumors be cured?

A localized tumor that is completely removed by surgery may be treated with curative intent. However, cure cannot be guaranteed, and follow-up is still needed. When disease has spread, treatment may often control it for a long time even if complete removal is not possible.

What tests are used to plan treatment?

Planning usually includes CT or MRI scans, pathology review, and blood or urine testing when a hormone-producing tumor is suspected. Specialized somatostatin receptor imaging may also be used to map disease and assess whether certain treatments are suitable.

What is PRRT for pancreatic neuroendocrine tumors?

PRRT is a targeted nuclear medicine treatment used for selected neuroendocrine tumors that show somatostatin receptors on specialized imaging. It delivers radiation linked to a receptor-targeting substance, with the aim of treating tumor cells while limiting exposure to normal tissues. Eligibility depends on imaging, kidney and bone marrow function, prior treatments, and other clinical factors.

Will pancreatic surgery cause diabetes or digestive problems?

It can, but not everyone develops these problems. The risk depends on how much pancreatic tissue is removed and how well the remaining pancreas functions. Some people may need pancreatic enzyme replacement, nutrition advice, or diabetes monitoring after surgery.

References

• National Cancer Institute
• European Society for Medical Oncology
• North American Neuroendocrine Tumor Society
• National Comprehensive Cancer Network
• European Neuroendocrine Tumor Society

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.